Drugs / OPC-108459
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02069119 | Feb 2014 → Aug 2015 | atrial fibrillation | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01483183 | Nov 2011 → Oct 2015 | paroxysmal atrial fibrillation, persistent atrial fibrillation | Otsuka Pharmaceutical Development & Commercialization, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPC-108459 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01483183 ↗ |
| Route | Intravenous | “10-minute constant rate IV infusion” NCT01483183 ↗ |